A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

CJ, Pepine; EM, Handberg; RM, Cooper-DeHoff; RG, Marks; P, Kowey; FH, Messerli; G, Mancia; JL, Cangiano; D, Garcia-Barreto; M, Keltai; S, Erdine; HA, Bristol; HR, Kolb; GL, Bakris; JD, Cohen; WW, Parmley

doi:10.1001/jama.290.21.2805

Public

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Shared by NobleBlocks on Dec 1, 2003 • 12:00 AM UTC

Authors:

Pepine CJ

Handberg EM

Cooper-DeHoff RM

Abstract

Context Despite evidence of efficacy of antihypertensive agents in treating hypertensive patients, safety and efficacy of antihypertensive agents for coronary artery disease (CAD) have been discerned only from subgroup analyses in large trials.Objective To compare mortality and morbidity outcomes in...

Discussions